Zim Laboratories Ltd Share Price

Q: What is the share price of Zim Laboratories Ltd today?

Zim Laboratories Ltd share price as on 18 Nov 2025 is ₹72.19

Pharmaceuticals

NSE: ZIMLAB Small Cap ISIN: INE518E01015

As on 19 November 2025 at 02:57 IST

₹72.19

-0.40

(-0.55%)

Sell Buy

Over 1 Month

6.06%

Over 6 Months

-21.94%

Over 1 Year

-30.44%

Over 3 Years

-35.26%

Zim Laboratories Ltd Summary

Close ₹72.59

Open ₹73.97

High ₹74.09

Low ₹72.40

Volume 57,681

Net Turnover (in Cr) ₹0.42

52Wk High ₹128

52Wk Low ₹67

52Wk High / Low

128

Zim Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹353.77

EPS (TTM) 1.68

Book Value (BV) 49.93

Div. Yield -

P/E (TTM) 43.43

Price/Book Value 1.46

Delivery % 44.88 %

Face Value 10

Key Ratios

PE Ratio 33.28

PB Ratio 1.61

EV to Sales 1.35

PEG Ratio -1.11

ROA 3.24

ROE 4.93

Debt-Equity 0.48

Net Profit Margin 3.13

Operating Profit Margin 13.02

Zim Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	384.82	372.61	404.94	337.83	309.60
Total Expenses	366.81	348.97	369.59	316.79	294.19
Profit Before Tax	18.01	23.64	35.35	21.04	10.23
Profit After Tax	12.16	17.25	24.43	14.55	7.32
Operating Profit After Depreciation	29.40	30.57	40.93	29.35	26.31

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	190.69	179.59	117.81	112.29	112.64
Total Non Current Assets	240.72	219.17	150.63	129.49	133.02
Total Current Assets	231.31	227.65	190.95	212.14	191.76
Total Assets	472.02	446.82	341.58	341.63	324.78
Total Shareholder's Fund	252.24	238.75	200.35	175.71	160.75

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	41.15	16.28	38.17	49.21	31.85
Net Cash Used In Investing Activities	-39.70	-72.63	-35.71	-14.21	-5.95
Net Cash Used In Financing Activities	-9.10	59.53	0.55	-32.97	-25.97

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	381.26	370.16	402.96	334	306.08
Total Expenses	363.64	347.12	367.04	314.70	292.32
Profit Before Tax	17.61	23.04	35.92	19.30	8.58
Profit After Tax	11.74	16.76	25.01	13.01	5.62
Operating Profit After Depreciation	29	29.96	41.49	27.60	24.65

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	185.21	177.22	115.57	109.63	109.05
Total Non Current Assets	248.04	224.79	156.23	134.83	137.31
Total Current Assets	216.35	217.71	178.64	200.60	182.97
Total Assets	464.39	442.50	334.87	335.42	320.28
Total Shareholder's Fund	244.51	231.95	194.18	170.11	157.05

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	50.60	11.47	35.23	47.03	31.90
Net Cash Used In Investing Activities	-41.31	-71.94	-35.21	-14.42	-5.70
Net Cash Used In Financing Activities	-9.10	59.53	0.55	-32.97	-25.96

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	88.71	71.76	108.73	96.33	92.14
Total Expenses	82.96	67.50	94.14	84.77	82.61
Profit Before Tax	-0.35	-2.42	8.10	5.70	2.96
Profit After Tax	-0.42	-1.87	4.88	4	2.38
Operating Profit after Depreciation	7.79	5.74	16.30	13.31	10.85

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	88.39	71.43	108.52	95.40	89.72
Total Expenses	82.22	67.09	93.28	83.63	81.34
Profit Before Tax	0.22	-2.27	8.65	6.03	1.84
Profit After Tax	0.12	-1.69	5.42	4.35	1.22
Operating Profit after Depreciation	8.21	5.82	16.79	13.53	9.70

Zim Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 71.96

S2 71.34

S3 70.27

Pivot 73.03

R1 73.65

R2 74.72

R3 75.34

Moving Average

20 SMA 72.04

50 SMA 72.75

100 SMA 85.33

200 SMA 88.90

Zim Laboratories Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

AGM 30/09/2021 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published on 09.09.2021 in respect of 37th Annual General Meeting of the Company scheduled to be held on 30th September, 2021, in in the following Newspaper :- 1) The Financial Express (English) all India Edition 2) Indian Express (English) Nagpur Edition 3) Loksatta (Marathi). (As Per BSE Announcement dated on 09.09.2021) The 37th Annual General Meeting of the Company was held on 30.09.2021 and in this regard, please find enclosed proceedings of the Annual General Meeting as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated 01.10.2021)

AGM Date: 19 Sep 2022

AGM 19/09/2022 Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following documents: 1.Notice of the 38th Annual General Meeting (including e-voting instructions) 2.Annual Report for F.Y. 2021-22 The 38th Annual General Meeting of the members of ZIM Laboratories Limited will be held on Monday, 19th September, 2022 at 12.30 p.m. IST through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). The Annual Report along with the Notice of the AGM for the F.Y. 2021-22 is also available on the website of the Company at www.zimlab.in Further, the Register of Members and the Share Transfer Book of the Company will remain closed from Tuesday, 13th September, 2022 till Monday, 19th September, 2022 (both days inclusive) for the purpose of Annual General Meeting. (As Per BSE Announcement Dated on 26.08.2022) The 37th Annual General Meeting of the Company was held on 30.09.2021 and in this regard, please find enclosed proceedings of the Annual General Meeting as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The 38th Annual General Meeting of the Company was held on 19.09.2022 and in this regard, please find enclosed the following :- 1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2) Report of the Scrutinizer dated 20.09.2022. The 38th Annual General Meeting of the Company was held on 19.09.2022 and in this regard, please find enclosed the following :- 1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2) Report of the Scrutinizer dated 20.09.2022. (As Per BSE Announcement Dated on 20.09.2022) Zim Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. This is to inform that the date of Annual General Meeting(AGM) mentioned in our earlier filing dt.20.09.2022 related to proceeding of AGM was inadvertently mentioned as 30.09.2021 instead of 19.09.2022. Please refer revised disclosure as mentioned below: The 38th Annual General Meeting of the Company was held on 19.09.2022 and in this regard, please find enclosed proceedings of the Annual General Meeting as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 21.09.2022)

AGM Date: 10 Jul 2023

Pursuant to Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in compliance with various circulars issued by the Ministry of Corporate Affairs, we submit herewith copies of newspaper advertisements published, intimating that the 39th Annual General Meeting of the Company is scheduled to be held on Monday, 10th July, 2023 through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in the following Newspapers : 1. The Financial Express (English) all India Edition 2. Indian Express (English), Nagpur Edition 3. Loksatta (Marathi) Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following documents: 1.Notice of the 39th Annual General Meeting (including e-voting instructions). 2. Annual Report for F.Y. 2022-23 The 39th Annual General Meeting of the members of ZIM Laboratories Limited will be held on Monday, 10th July, 2023 at 11:30 a.m. IST through Video Conferencing ('VC') / Other Audio-Visual Means ('OAVM'). Further, the Register of Members and the Share Transfer Book of the Company will remain closed from Tuesday, 04th July, 2023 till Monday, 10th July, 2023 (both days inclusive) for the purpose of Annual General Meeting. (As Per BSE Announcement dated on 16.06.2023) Pursuant to Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published in respect of 39th Annual General Meeting of the Company scheduled to be held on Monday, 10th July,2023, in the following Newspapers:- 1. The Financial Express (English) all India Edition 2. Indian Express (English) Nagpur Edition 3. Loksatta (Marathi). (As Per BSE Announcement Dated on 17.06.2023) The 39th Annual General Meeting of the Company was held on 10th July, 2023 at 11:30 a.m. (IST) and in this regard, Please find the following : 1) Voting results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. 2) Report of the Scrutinizer dated 10.07.2023. The AGM concluded at 12:12 p.m. (IST) The 39th Annual General Meeting(AGM) of the Company was held on 10th July, 2023, and in this regard, we would like to inform you regarding the proceedings of the AGM as per Regulation 30 of SEBI(LODR) Regulations, 2015. (As Per BSE Announcement dated on 10.07.2023)

AGM Date: 27 Jun 2024

AGM 27/06/2024 Pursuant to Regulation 42 of SEBI (LODR) Regulations, 2015, the Board in its meeting held on 03rd June, 2024 decided that the Register of Members and Share Transfer Book will remain closed from 21st June, 2024 till 27th June, 2024 for the purpose of AGM. (As Per BSE Announcement dated on 05.06.2024) The 40th AGM of the Company was held on 27th June, 2024 and this regard please find attached the voting results as per Reg 44 of SEBI LODR and Scrutinizer''s Report. (As Per BSE Announcement Dated on 27.06.2024)

AGM Date: 27 Jun 2025

The Annual General Meeting of the Company is scheduled to be held on Friday, June 27, 2025 The Notice of 41st Annual General Meeting of the Company along with the Annaul Report for the F.Y 2024-25 is enclosed. Corrigendum to the Annual Report for the F.Y 2024-25 (As Per BSE Announcement Dated on: 05.06.2025) Voting Results and Scrutiniser''s Report of the 41st Annual General Meeting of the Company held on Friday, 27th June, 2025 (As per BSE Announcement Dated on 27/06/2025)

EGM Date: 29 Jun 2022

EGM 29/06/2022 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors on 06th June, 2022 have approved the issuance of Notice convening an Extra-ordinary General Meeting ('EGM') of the members of the Company to be held on Wednesday, 29th June, 2022 at 12:30 p.m. through Video Conferencing / Other Audio Visual Means, to seek approval of the members of the Company in respect of the proposed appointments/reappointments of the Directors. In continuation to our letter dated 06.06.2022, wherein we had intimated that the Board of Directors have approved issuance of Notice for convening the Extraordinary General Meeting of the Company, please find enclosed the EGM Notice dated 06.06.2022 under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 seeking the consent of the shareholders on the matters set out in the notice, which is being sent though electronic mode to members of the Company. The notice of EGM is also available on Company's website at www.zimlab.in. (As per BSE Announcement Dated on 07/06/2022) In continuation to our letter dated 07.06.2022, wherein we had intimated that the Notice for convening the Extraordinary General Meeting (EGM) of the Company has been sent to Shareholders, we would like to inform you that there is a typographical error in Resolution No. 6 of the Notice and its explanatory statement thereto which has been rectified. The revised notice has been sent to the shareholders through electronic mode and the same is enclosed herewith for your reference. The revised notice of EGM is also available on Company's website at www.zimlab.in. (As Per BSE Announcement dated on 08.06.2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published on 08.06.2022, in respect of Extraordinary General Meeting of the Company scheduled to be held on 29.06.2022, in the following Newspaper : 1) The Financial Express (English) all India Edition 2) Indian Express (English) Nagpur Edition 3) Loksatta (Marathi) Newspaper. (As Per BSE Announcement dated on 09.06.2022) The Extraordinary General Meeting of the Company was held on 29th June, 2022 at 12:30 p.m. through VC/OAVM and in this regard, please find enclosed proceedings of the Extraordinary General Meeting as required under the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As per BSE Announcement Dated on 29/06/2022) The Extraordinary General Meeting of the Company was held on Wednesday, 29th June, 2022 at 12:30 p.m. through Video Conferencing / Other Audio-Visual Means. Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith particulars of voting results of voting conducted through Remote E-voting and voting through electronic system during the EGM in respect of all the resolutions as set out in the Notice dated 07th June, 2022. We also enclose herewith the Scrutinizer's Consolidated Report. All the resolutions set out in the Notice of the EGM were approved with the requisite majority. (As Per BSE Announcement dated on 30.06.2022)

EGM Date: 12 Dec 2022

This is to inform you that the Board of Directors at its meeting held today have inter-alia considered and approved the following: Increase in Authorized Share Capital of the Company from Rs. 25,00,00,000/- divided into 2,50,00,000 Equity shares of 10/- each to Rs. 75,00,00,000/- divided into 7,50,00,000 equity shares of Rs. 10/- each and consequent amendment to Clause V of the Memorandum of Association of the Company, subject to the approval of the Shareholders in the General Meeting; and Issuance of Bonus Shares in the proportion of 2 (TWO) Equity Shares of Rs 10/- each for every 1 (ONE) existing Equity Share of Rs 10/- each held by the Shareholders of the Company as on the record date., subject to the approval of the Shareholders in the General Meeting. Convening Extraordinary General Meeting of the Company to be scheduled on Monday, 12th December, 2022 through video conferencing / other audio visual means for consideration and approval of items mentioned in (b) & (c) above by the shareholders of the Company In continuation to the outcome of the Board Meeting dt.12th November, 2022 and pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the notice of the EGM scheduled to be held on 12th December, 2022 through Video Conferencing (VC) / Other Audio Visual Means (OAVM) seeking the consent of the shareholders on the matters set out in the notice. The notice of EGM is also available on Company's website at www.zimlab.in. The cut-off date for remote e-voting is Monday, 05th December, 2022. The remote e-voting shall commence on Friday, 09th December, 2022 at 09:00 a.m. and ends on Sunday, 11th December, 2022 at 05:00 p.m. (As Per BSE Announcement Dated on 18.11.2022) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of newspaper advertisements published on 19th November, 2022 in respect of Extraordinary General Meeting of the Company scheduled to be held on 12th December, 2022, in the following Newspaper :- 1) The Financial Express (English) all India Edition 2) Indian Express (English) Nagpur Edition 3) Loksatta (Marathi). (As Per BSE Announcement Dated on 19/11/2022) This is to inform you that the Extraordinary General Meeting was held on Monday, 12th December, 2022, through Video Conferencing/ Other Audio Visual Means. Please find enclosed the Summary of Proceedings of Extraordinary General Meeting as required under Regulation 30 read with Part A, Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Extraordinary General Meeting of the Company was held on Monday, 12th December, 2022 at 12:30 p.m. through Video Conferencing / Other Audio-Visual Means. Pursuant to the requirements of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith particulars of voting results of voting conducted through Remote E-voting and voting through electronic system during the EGM in respect of all the resolutions as set out in the Notice dated 12th November, 2022. We also enclose herewith the Scrutinizer's Consolidated Report. All the resolutions set out in the Notice of the EGM were approved with the requisite majority. (As Per BSE Announcement Dated on 12/12/2022) With reference to the captioned subject, we hereby inform that the Capital Clause i.e., Clause V of the Company's Memorandum of Association (MOA) has been amended, vide Ordinary Resolution passed by the Members in the Extraordinary General Meeting (EGM) of the Company held on Monday, 12th December, 2022. Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, details of amendment are mentioned below: The amended clause is as below: 'V. The Authorised Share Capital of the Company is Rs. 75,00,00,000 (Rupees Seventy-Five Crores only) divided into 7,50,00,000 (Seven Crores Fifty Lakh) Equity shares of Rs. 10 each. (As Per BSE Announcement dated on 13.12.2022)

Zim Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Zim Laboratories Ltd Top Mutal Funds Invested

No data available

Zim Laboratories Ltd News

Zim Laboratories to hold board meeting

On 12 November 2025

06 Nov 2025, 03:39 pm

Zim Laboratories Ltd leads losers in 'B' group

PSP Projects Ltd, BirlaNu Ltd, Kabra Extrusion Technik Ltd and Vishnu Chemicals Ltd are among the other losers in the BSE's 'B' group today, 04 August 2025.

04 Aug 2025, 02:45 pm

Zim Laboratories to conduct board meeting

On 7 August 2025

01 Aug 2025, 03:51 pm

Zim Laboratories AGM scheduled

On 27 June 2025

04 Jun 2025, 05:05 pm

Zim Laboratories to announce Quarterly Result

On 20 May 2025

15 May 2025, 12:30 pm

Zim Laboratories Ltd Stock Analysis

Annual revenue for Zim Laboratories Ltd increased by 3.00% to ₹381.26 crore in FY 2025 from ₹370.16 crore in FY 2024.
Annual Net Profit for Zim Laboratories Ltd decreased by 29.91% to ₹11.74 crore in FY 2025 from ₹16.76 crore in FY 2024.
Promoter Shareholding in Zim Laboratories Ltd decreased by 0.02% in the most recent quarter, from 33.26% in June 2025 to 33.26% in September 2025.
Zim Laboratories Ltd delivered a 1-year return of -30.44% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Zim Laboratories Ltd share price moved down by 0.55% from its previous close of INR ₹72.59. The latest Zim Laboratories Ltd share price is INR ₹72.19.
Zim Laboratories Ltd share price today has been at a low of 72.01 and a high of 72.78. Over the past 52 weeks, the Zim Laboratories Ltd share price has seen a low of 67 and a high of 128.